US Patent Issued to The University of North Carolina at Chapel Hill on Sept. 1 for "Methods and compositions for chimeric antigen receptor targeting cancer cells" (American, Chinese Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,721,892, issued on Sept. 1, was assigned to The University of North Carolina at Chapel Hill (Chapel Hill, N.C.).

"Methods and compositions for chimeric antigen receptor targeting cancer cells" was invented by Gianpietro Dotti (Chapel Hill, N.C.), Chuang Sun (Hangzhou, China), Peishun Shou (Cary, N.C.) and Yang Xu (Chapel Hill, N.C.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides chimeric antigen receptors (CAR) and methods of use in the treatment of diseases and disorders."

The patent was filed on Oct. 30, 2020, under Application No. 17/773,281.

*For further information, including images, charts and tables, please visit: ...